GLPwatch
Papers (10589)
Page 177 of 177, ranked by citation count.
- Therapeutic potential of targeting ceramide for early cardiometabolic lipotoxicity in vivo study.
- Holistic Management of Obesity in Patients with Incidental Cancer After Unprovoked Deep Vein Thrombosis: A Cardiometabolic and Antithrombotic Framework.
- Changes in food cravings, dietary quality, body composition, and dietary intake during GLP-1 receptor agonist therapy: The CRAVE study.
- In early Parkinson disease, daily subcutaneous lixisenatide reduced motor disability progression at 12 mo.
- GLP-1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study.
- Cardiovascular Outcomes With Tirzepatide Versus GLP-1 Receptor Agonists in Overweight or Obesity: A Systematic Review and Meta-Analysis.
- Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Glucagon-Like Peptide-1 Receptor Agonists.
- [Pharmacological treatments for obesity : what does the future hold?]
- A retrospective audit of weight loss and health outcomes following bariatric surgery at a tertiary public hospital.
- Managing post-bariatric hypoglycemia: a systematic review of pharmacological therapies.
- Tirzepatide ameliorates type 2 diabetes-associated male reproductive dysfunction via modulation of the Nrf2/Keap1 pathway.
- Multidimensional Predictors of Tirzepatide Efficacy: Clinical, Genetic, and Molecular Biomarkers for Glycemic, Weight, and Organ Protection.
- Orforglipron for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity or overweight: Study design and baseline characteristics of ATTAIN-OSA, a phase 3 trial.
- Pre-Treatment Concerns and Their Association With Functioning and Well-Being During Incretin-Based Therapy: A Cross-Sectional Study.
- Special Considerations When Using GLP-1 Receptor Agonists in the Treatment of Obesity and Diabetes Mellitus Type 2 in Older Adults.
- Insulin degludec/liraglutide (Xultophy 100/3.6) for type 2 diabetes.
- Antiemetic effect of acupressure wristbands for GLP-1 medication associated nausea.
- Evolving utilization of bariatric surgery since the rise of semaglutide and tirzepatide.
- Efficacy of dulaglutide after switching from incretin-related drugs in patients with type 2 diabetes and inadequate glycemic control.
- Prescription Sequence Symmetry Analysis of Glucagon-Like Peptide-1 Receptor Agonists and Neuropsychiatric Conditions.
- Unanticipated Adverse Events With Tirzepatide: Three Cases Underscoring the Importance of Postmarketing Monitoring.
- [Cardiovascular effects of liraglutide therapy in patients with type 2 diabetes : Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER)].
- [Diabetes Mellitus Type 2: Recent Publications and New Drugs].
- Variable Effects of Glucagon Like Peptide-1 Receptor Agonists on Body Composition in Older Women.
- The impact of nutrition, exercise, and pharmacotherapy on menstrual health in adolescents with overweight and obesity.
- Pharmacosimilars In Obesity Medicine: Informed Choice, Appropriate Choice.
- Incretin-Based Therapies in Sports: Pharmacological Mechanisms, Performance-Enhancing Potential, and Anti-Doping Implications-A Narrative Review.
- Switching patterns of GLP-1 receptor agonists from 2018 to 2025 in the largest private healthcare network in Poland.
- Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Outcomes in Patients With Atherosclerotic Cardiovascular Disease and Obesity Without Diabetes.